Bio-IT World March 1, 2021
Allison Proffitt

Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.

Using numbers current as of January 19, 2021, Denny reported that the All of Us program has more than 366,000 participants. More than 233,000 have shared access to their medical records, and more than 279,000 have contributed some biosamples which includes physical measurements, blood, saliva, and/or urine samples. The All of Us program did pause recruitment in March 2020 because of the pandemic, but recruitment resumed in late 2020, Denny said and numbers are again increasing.

Participants come from all 50 states and all available ages (18 and older), though...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article